Nuvectis Pharma (NVCT) stock Forecast for 2022 – 2026

Nuvectis Pharma (NVCT) stock Forecast for 2022 – 2026

Last update: 05-29-2022, 6:25

Sector: Healthcare

The share price of Nuvectis Pharma, Inc. (NVCT) now

What analysts predict:: $20.5

52-week high/low: $20.92 / $3.08

50/200 Day Moving Average: $10.76 / $9.42

This figure corresponds to the average price over the previous 50/200 days. For Nuvectis Pharma stocks, the 50-day moving average is the support level today.

For Nuvectis Pharma stocks, the 200-day moving average is the support level today.

Are you interested in Nuvectis Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Nuvectis Pharma stock price in 2022, 2023, 2024, 2025, 2026. How much will one Nuvectis Pharma share be worth in 2022 - 2026?

When should I take profit in Nuvectis Pharma stock? When should I record a loss on Nuvectis Pharma stock? What are analysts' forecasts for Nuvectis Pharma stock? What is the future of Nuvectis Pharma stock?

We forecast Nuvectis Pharma stock performance using neural networks based on historical data on Nuvectis Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Nuvectis Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Nuvectis Pharma shares. This happens once a day.




Historical and forecast chart of Nuvectis Pharma stock

The chart below shows the historical price of Nuvectis Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Nuvectis Pharma stock price can be found in the table below.

Long-term forecasts by years.

Nuvectis Pharma daily forecast for a month

Date Target Pes. Opt. Vol., %
May 31 16.50 16.13 16.76 3.87
Jun 01 16.61 16.40 17.11 4.31
Jun 02 16.82 16.31 17.26 5.81
Jun 03 17.23 16.61 17.99 8.28
Jun 04 17.62 16.91 17.95 6.13
Jun 05 17.83 17.20 18.28 6.28
Jun 06 17.72 16.88 17.99 6.61
Jun 07 18.03 17.39 18.77 7.96
Jun 08 18.45 17.95 19.20 6.97
Jun 09 18.70 18.01 19.07 5.92
Jun 10 18.26 17.91 18.61 3.92
Jun 11 18.58 18.33 19.18 4.68
Jun 12 18.86 18.56 19.74 6.40
Jun 13 19.63 18.96 20.49 8.08
Jun 14 19.05 18.57 19.37 4.31
Jun 15 19.27 18.44 20.00 8.47
Jun 16 19.74 19.07 20.46 7.27
Jun 17 19.99 19.53 20.80 6.51
Jun 18 19.63 19.13 20.35 6.41
Jun 19 19.49 18.87 20.18 6.94
Jun 20 19.19 18.65 19.74 5.87
Jun 21 18.57 18.13 18.94 4.48
Jun 22 18.19 17.66 19.05 7.85
Jun 23 17.79 17.47 18.26 4.52
Jun 24 18.73 18.15 19.58 7.87
Jun 25 18.19 17.95 18.47 2.86
Jun 26 17.40 16.75 17.85 6.54
Jun 27 16.92 16.48 17.68 7.27
Jun 28 17.32 16.98 17.97 5.81
Jun 29 17.43 16.65 17.64 5.90

Nuvectis Pharma Daily Price Targets


Nuvectis Pharma Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $16.50. Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 3.722%.

Pessimistic target level: 16.13

Optimistic target level: 16.76


Nuvectis Pharma Stock Forecast 06-01-2022.

Forecast target price for 06-01-2022: $16.61. Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 4.136%.

Pessimistic target level: 16.40

Optimistic target level: 17.11


Nuvectis Pharma Stock Forecast 06-02-2022.

Forecast target price for 06-02-2022: $16.82. Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.495%.

Pessimistic target level: 16.31

Optimistic target level: 17.26


Nuvectis Pharma Stock Forecast 06-03-2022.

Forecast target price for 06-03-2022: $17.23. Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 7.645%.

Pessimistic target level: 16.61

Optimistic target level: 17.99


Nuvectis Pharma Stock Forecast 06-04-2022.

Forecast target price for 06-04-2022: $17.62. Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.773%.

Pessimistic target level: 16.91

Optimistic target level: 17.95


Nuvectis Pharma Stock Forecast 06-05-2022.

Forecast target price for 06-05-2022: $17.83. Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.911%.

Pessimistic target level: 17.20

Optimistic target level: 18.28


NVCT (NVCT) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 16.18 15.21 17.66 13.92
Jul. 15.53 13.14 17.05 22.95
Aug. 15.16 14.00 15.97 12.33
Sep. 13.03 11.50 14.29 19.53
Oct. 11.03 10.39 12.77 18.65
Nov. 10.10 8.48 11.23 24.46
Dec. 10.97 10.22 12.22 16.34

Nuvectis Pharma forecast for this year


Nuvectis Pharma Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $16.176. Pessimistic: $15.21. Optimistic: $17.66


Nuvectis Pharma Stock Prediction for Jul 2022

An downtrend is forecast for this month with an optimal target price of $15.529. Pessimistic: $13.14. Optimistic: $17.05


Nuvectis Pharma Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $15.1563. Pessimistic: $14.00. Optimistic: $15.97


Nuvectis Pharma Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $13.0344. Pessimistic: $11.50. Optimistic: $14.29


Nuvectis Pharma Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $11.0271. Pessimistic: $10.39. Optimistic: $12.77


Nuvectis Pharma Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $10.1008. Pessimistic: $8.48. Optimistic: $11.23


Nuvectis Pharma Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $10.9695. Pessimistic: $10.22. Optimistic: $12.22




Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 11.28 9.59 13.04 26.47
Feb 10.94 10.48 11.81 11.30
Mar 11.44 9.89 12.11 18.34
Apr 10.43 8.91 11.21 20.48
May 8.95 8.54 9.31 8.27
Jun 9.24 7.96 9.87 19.29
Jul 10.75 9.06 11.57 21.75
Aug 10.02 8.68 10.42 16.73
Sep 10.52 9.87 11.28 12.50
Oct 9.60 8.50 10.94 22.28
Nov 11.25 10.69 12.94 17.39
Dec 12.19 11.27 13.63 17.35

Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 12.83 12.21 14.47 15.60
Feb 10.78 9.12 11.53 20.93
Mar 9.89 9.16 10.55 13.13
Apr 9.16 7.86 10.44 24.74
May 8.52 7.97 9.37 14.91
Jun 8.28 7.75 9.32 16.87
Jul 9.42 8.71 10.82 19.51
Aug 10.89 9.93 11.44 13.14
Sep 9.24 8.70 10.60 17.94
Oct 9.59 8.74 10.68 18.13
Nov 10.47 9.34 11.20 16.64
Dec 10.14 9.63 11.47 16.08



Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 11.74 10.92 12.89 15.30
Feb 12.56 11.03 13.66 19.30
Mar 11.35 10.42 13.03 20.04
Apr 10.67 10.10 11.89 15.08
May 11.97 11.21 13.39 16.28
Jun 10.85 9.20 11.91 22.77
Jul 12.48 11.75 13.40 12.29
Aug 11.85 10.43 12.44 16.19
Sep 10.41 9.12 11.90 23.43
Oct 11.01 10.19 11.58 11.98
Nov 11.98 10.88 13.75 20.91
Dec 12.24 10.33 12.88 19.77

Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 14.22 12.89 16.33 21.08
Feb 15.11 14.11 15.92 11.39
Mar 13.63 12.13 15.07 19.53
Apr 13.27 11.63 14.41 19.34
May 12.74 11.39 14.17 19.60
Jun 14.81 13.86 16.64 16.73
Jul 14.81 12.53 16.85 25.66
Aug 16.20 13.61 17.17 20.75
Sep 15.32 14.13 16.82 16.03
Oct 15.72 14.49 18.20 20.38
Nov 16.54 15.68 18.85 16.84
Dec 17.56 16.37 18.62 12.08

Nuvectis Pharma information and performance

Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Nuvectis Pharma Address

1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, UNITED STATES

Market Capitalization: 197 126 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.832

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 12717800

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.